CS208475B2 - Method of making the hydrogencitrate of the alcalic met - Google Patents

Method of making the hydrogencitrate of the alcalic met Download PDF

Info

Publication number
CS208475B2
CS208475B2 CS783982A CS398278A CS208475B2 CS 208475 B2 CS208475 B2 CS 208475B2 CS 783982 A CS783982 A CS 783982A CS 398278 A CS398278 A CS 398278A CS 208475 B2 CS208475 B2 CS 208475B2
Authority
CS
Czechoslovakia
Prior art keywords
citric acid
weight
citrate
urine
ions
Prior art date
Application number
CS783982A
Other languages
Czech (cs)
English (en)
Inventor
Rolf Madaus
Werner Stumpf
Klaus Goerler
Alfonso C Beltran
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of CS208475B2 publication Critical patent/CS208475B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS783982A 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met CS208475B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2727304A DE2727304C2 (de) 1977-06-16 1977-06-16 Saures Alkalicitrat, dessen Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
CS208475B2 true CS208475B2 (en) 1981-09-15

Family

ID=6011690

Family Applications (1)

Application Number Title Priority Date Filing Date
CS783982A CS208475B2 (en) 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met

Country Status (26)

Country Link
US (1) US4820870A (ro)
JP (1) JPS545912A (ro)
AR (1) AR219109A1 (ro)
AU (1) AU519032B2 (ro)
BE (1) BE868089A (ro)
BG (1) BG41657A3 (ro)
CA (1) CA1133506A (ro)
CH (1) CH634813A5 (ro)
CS (1) CS208475B2 (ro)
DE (1) DE2727304C2 (ro)
DK (1) DK270578A (ro)
FR (1) FR2394513A1 (ro)
GB (1) GB1583840A (ro)
GR (1) GR64516B (ro)
HK (1) HK46481A (ro)
IL (1) IL54734A (ro)
IT (1) IT1214864B (ro)
MX (1) MX4999E (ro)
NL (1) NL174345C (ro)
PL (1) PL118528B1 (ro)
PT (1) PT68096A (ro)
RO (1) RO76941A (ro)
SE (1) SE438851B (ro)
SU (1) SU812167A3 (ro)
YU (1) YU41105B (ro)
ZA (1) ZA783409B (ro)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6393968A (ja) * 1986-10-06 1988-04-25 株式会社フジタ 地下立体駐車場
JPH02104870A (ja) * 1988-10-11 1990-04-17 Iwataro Moriyama 駐車装置
GB9221111D0 (en) * 1992-10-07 1992-11-18 Cerestar Holding Bv Process for the production of an alkali metal citrate
DE4328577C2 (de) * 1993-08-25 1997-09-11 Madaus Ag Alkalicitrate und deren Verwendung als Arzneimittel
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
EP0673913B1 (de) * 1994-03-23 1999-02-10 Madaus Ag Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
DE4409948A1 (de) * 1994-03-23 1995-09-28 Madaus Ag Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
RU2238735C1 (ru) * 2003-05-29 2004-10-27 Семин Михаил Викторович Средство для литолиза мочевых камней и способ его получения
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
KR20190073461A (ko) * 2016-10-27 2019-06-26 스테파니 에이. 세이사스-미켈러스 신결석의 예방 및 치료를 위한 주스 음료
PL238507B1 (pl) 2018-11-27 2021-08-30 Kozak Dariusz P H M Polcomm Wiertło z podwójnymi nacinakami
CN111116350A (zh) * 2019-12-28 2020-05-08 湖南九典制药股份有限公司 一种枸橼酸氢钾钠的制备方法
CN114404142B (zh) * 2022-02-23 2024-03-29 天津富勤科技股份有限公司 一种产生中性或弱酸性蒸汽的自发热眼罩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968843C (de) * 1953-11-29 1958-04-03 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von pharmakologisch wirksamen Magnesiumsalzen der Citronensaeure
DE1016251B (de) * 1955-01-22 1957-09-26 Adolf Christian Josef Opferman Verfahren zur Herstellung von zur Behandlung der Lungentuberkulose dienendem Monomagnesiumdicalciumcitrat
US3658969A (en) * 1969-11-14 1972-04-25 Codex Sa Pharmaceutical compositions useful in citric acid therapy

Also Published As

Publication number Publication date
NL7805747A (nl) 1978-12-19
IL54734A (en) 1982-09-30
NL174345C (nl) 1984-06-01
BG41657A3 (en) 1987-07-15
IT1214864B (it) 1990-01-18
HK46481A (en) 1981-09-25
RO76941A (ro) 1981-06-22
PT68096A (de) 1978-06-01
CA1133506A (en) 1982-10-12
GR64516B (en) 1980-04-09
YU41105B (en) 1986-12-31
DK270578A (da) 1978-12-17
IL54734A0 (en) 1978-07-31
DE2727304A1 (de) 1979-01-04
SE7806684L (sv) 1978-12-17
NL174345B (nl) 1984-01-02
YU142778A (en) 1982-10-31
BE868089A (fr) 1978-12-14
GB1583840A (en) 1981-02-04
CH634813A5 (de) 1983-02-28
US4820870A (en) 1989-04-11
AR219109A1 (es) 1980-07-31
SE438851B (sv) 1985-05-13
FR2394513A1 (fr) 1979-01-12
IT7824553A0 (it) 1978-06-14
ZA783409B (en) 1979-07-25
PL207657A1 (pl) 1979-06-04
SU812167A3 (ru) 1981-03-07
AU519032B2 (en) 1981-11-05
DE2727304C2 (de) 1982-12-02
MX4999E (es) 1983-02-02
FR2394513B1 (ro) 1982-11-19
AU3716278A (en) 1979-12-20
PL118528B1 (en) 1981-10-31
JPS545912A (en) 1979-01-17

Similar Documents

Publication Publication Date Title
CS208475B2 (en) Method of making the hydrogencitrate of the alcalic met
Prescott Pharmacokinetic drug interactions
KR100412219B1 (ko) 분자 요오드의 경구투여용 제약 조성물
US20130296433A1 (en) Phosphorus binder composition for treatment of hyperphosphatemia
SK12692001A3 (sk) Zmesi valdecoxibu
JPH0261924B2 (ro)
JPS6075435A (ja) 経口抗糖尿病剤用の新規ガレヌス製剤
US5006551A (en) Composition for destroying malignant tumors
CZ20012661A3 (cs) Matricová tableta pro prodlouľené uvolňování gliclazidu po orálním podání
NZ208417A (en) Orally administrable compositions having improved release of antidiabetic substances
FR2688405A1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
JP2021512081A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む安定な薬剤学的組成物
US20170312309A1 (en) Intradialytic administration of sodium thiosulfate
US4870105A (en) Phosphorus binder
CA3009332A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
JP2811331B2 (ja) 骨形成促進剤
EP0074426B1 (en) Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
Roberge et al. Use of sodium polystyrene sulfonate in a lithium overdose
US4447455A (en) Oral urolithiasis remedy
US4400535A (en) Acidic alkali citrate and compositions for adjusting the pH of urine
JP6063939B2 (ja) L−ヒスチジンおよびその誘導体の新規用途
US7855191B2 (en) Agent having a destructive effect on malignant tumors and method for the production thereof
Taraszka et al. Effect of dissolution rate of sulfamethazine from tablets on absorption and excretion of sulfamethazine
KR20130047262A (ko) 제어된 방출성의 아스코르빈산 함유 경구용 정제 조성물 및 그 분석방법
KR20210012919A (ko) 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물